Home/Filings/4/0001104659-25-031813
4//SEC Filing

Oliviero James F III 4

Accession 0001104659-25-031813

CIK 0001651407other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 7:27 PM ET

Size

5.2 KB

Accession

0001104659-25-031813

Insider Transaction Report

Form 4
Period: 2025-04-02
Oliviero James F III
DirectorCEO, President and Director
Transactions
  • Sale

    COMMON STOCK

    2025-04-02$4.04/sh15,090$60,9643,759,929 total
Footnotes (2)
  • [F1]In connection with the vesting of restricted shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Oliviero's tax withholding obligations. Mr. Oliviero had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
  • [F2]Includes shares of restricted common stock, which vest over various time periods.

Issuer

Checkpoint Therapeutics, Inc.

CIK 0001651407

Entity typeother

Related Parties

1
  • filerCIK 0001434718

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 7:27 PM ET
Size
5.2 KB